CATX · Perspective Therapeutics, Inc.

$2.87 -0.01 (-0.17%)

Market Cap

$327.31M

114.05M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Former CEO	—	$439,816	—	—	$279,648	$46,180	$3,050	$768,694
Jennifer Streeter	COO	$337,834	—	—	$186,432	$28,379	$3,050	$555,695
Former CRDO	—	$299,998	—	—	$186,432	$25,200	$3,050	$514,680

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Former CEO	—	$353,450	—	—	—	$17,745	—	$371,195
Jennifer Streeter	COO	$256,672	—	—	—	$9,677	—	$266,349
Former CRDO	—	$244,149	—	—	—	$9,190	—	$253,339

Key facts CIK 728387 CUSIP 46489V302 13F (30d) 21 filings 20 filers Visit website Investor relations